Summary workshop report: Biopharmaceutics classification system—implementation challenges and extension opportunitiesOpinions expressed in this report are those of the authors and do not necessarily reflect the views or policies of the FDA.

Autor:	Polli, James E., Yu, Lawrence X., Cook, Jack A., Amidon, Gordon L., Borchardt, Ronald T., Burnside, Beth A., Burton, Philip S., Chen, Mei-Ling, Conner, Dale P., Faustino, Patrick J., Hawi, Amale A., Hussain, Ajaz S., Joshi, Hemant N., Kwei, Gloria, Lee, Vincent H.L., Lesko, Lawrence J., Lipper, Robert A., Loper, Alice E., Nerurkar, Shriniwas G., Polli, Joseph W., Sanvordeker, Dilip R., Taneja, Rajneesh, Uppoor, Ramana S., Vattikonda, Chandra S., Wilding, Ian, Zhang, Guohua
Zdroj:	Journal of Pharmaceutical Sciences; June 2004, Vol. 93 Issue: 6 p1375-1381, 7p
Abstrakt:	No abstract
Databáze:	Supplemental Index
Externí odkaz:	Zobrazit plný text záznamu Plný text